Fruquintinib: a potential new treatment for patients with refractory mCRC Presented ByProf. Nageshwara Arvind Dasari, MD Anderson Cancer Centre, TX, USA TrialPhase 3, FRESCO-2 ConferenceESMO 2022 16 November, 2022 17:21